Sander Deventer is the founder of VectorY. VectorY has raised $138M in total funding. Latest round: Series A. Based in Amsterdam, The Netherlands.
Sander van Deventer is the CEO of VectorY, a biotech company based in Amsterdam, Netherlands. VectorY focuses on developing vectorized antibody therapies for neurodegenerative diseases. The company recently closed a €129 million ($138 million) Series A financing round to advance its programs, including a lead candidate for Amyotrophic Lateral Sclerosis (ALS).
Full founder directory · Investor directory · Company funding database · Fundraising library